SBI Term Loan: RLLR: 8.15 | 7.25% - 8.55%
Canara Bank: RLLR: 8 | 7.15% - 9.85%
ICICI Bank: RLLR: -- | 8.5% - 9.65%
Punjab & Sind Bank: RLLR: 7.3 | 7.35% - 10.75%
Bank of Baroda: RLLR: 7.9 | 7.2% - 8.95%
Federal Bank: RLLR: -- | 7.35% - 9.6%
IndusInd Bank: RLLR: -- | 7.6% - 10%
Bank of Maharashtra: RLLR: 8.05 | 7% - 9.15%
Yes Bank: RLLR: -- | 7.4% - 10.54%
Karur Vysya Bank: RLLR: 8.8 | 8.5% - 10.65%
HDFC Bank: RLLR: -- | 7.75% - 13.2%
Axis Bank: RLLR: -- | 8% - 9.1%
IDBI Bank: RLLR: -- | 7.4% - 10%

Tenthpin launches life sciences innovation hub in Bengaluru

#Infrastructure News#Infrastructure#India#Karnataka#Bangalore
Bangalore News Desk Last Updated : 24 Sep 2026
Synopsis

Switzerland-based Tenthpin Management Consultants has launched an Innovation Hub in Bengaluru to develop AI- and cloud-based solutions for the Life Sciences industry. The centre at Global Tech Park, Koramangala, will function as a global Centre of Excellence focused on advanced therapies, including gene, cell and tissue treatments. Its capabilities will cover artificial intelligence, Internet of Medical Things, Advanced Therapy Medicinal Products and intelligent clinical supply chains. The company said the hub will support organisations from early-stage research and process optimisation through manufacturing and regulatory readiness. Tenthpin also plans to expand its Bengaluru team as part of its wider India growth strategy.

Switzerland-based Tenthpin Management Consultants has launched an Innovation Hub in Bengaluru, setting up a global Centre of Excellence focused on advanced therapies and digital solutions for the Life Sciences industry. The centre will use artificial intelligence, cloud technologies and other digital tools to support the development of complex gene, cell and tissue-based treatments. 
Located at Global Tech Park in Koramangala, the facility was inaugurated by Juergen Bauer, Founder and Chairman of the Executive Board of Tenthpin, in the presence of Michael Schmidt, Founder and Member of the Executive Board, and Sachin Bhure, Partner and Managing Director, Tenthpin India. The Bengaluru facility is the company’s third delivery centre in India, after Pune and Hyderabad. 
The Innovation Hub is intended to support biotechnology and pharmaceutical companies across different stages of their transformation, from early-stage research and process optimisation to scale-up, manufacturing and regulatory readiness. Tenthpin said AI-powered analytics, predictive modelling and cloud-based collaboration tools at the centre will help companies improve decision-making, reproducibility and resource utilisation while meeting quality and regulatory requirements. 
The centre will focus on technologies including Artificial Intelligence, Internet of Medical Things (IoMT), Advanced Therapy Medicinal Products (ATMPs) and intelligent clinical supply chains. Its solutions are expected to cater to pharmaceutical, biotechnology, healthcare, animal health and contract development and manufacturing organisations (CDMOs). 
Tenthpin said the Bengaluru hub will also work with research institutions, universities and industry partners in India. The facility is expected to develop AI-based products and accelerators aimed at helping Life Sciences companies manage complex processes, meet regulatory requirements and scale their operations. 
Bauer said the Bengaluru expansion reflects Tenthpin’s confidence in Indian talent and its technical capabilities. He added that the Bengaluru team, along with the company’s teams in Pune and Hyderabad, would contribute to developing digital solutions for global Life Sciences organisations. 
Schmidt said Bengaluru would play a key role as Tenthpin’s delivery headquarters in India. He highlighted the centre’s expertise in SAP Batch Release Hub (BRH), SAP Intelligent Clinical Supply Management (ICSM) and SAP Advanced Therapy Orchestration (ATO), along with Tenthpin’s own AI-powered, GxP-ready software solutions. 
Bhure said the company also intends to help Indian Life Sciences companies expand their innovation capabilities using local talent. He said Tenthpin plans to expand its Bengaluru presence and double its current team over the next two years. 
The company’s India expansion comes as it continues to increase its focus on technology-led solutions for the Life Sciences sector. Tenthpin currently has delivery centres in Bengaluru, Hyderabad and Pune. Its India workforce is around 175 employees, and the company plans to increase this to nearly 400 over the next 18 to 24 months, according to a recent company statement reported by United News of India. Bengaluru is expected to account for around 60% to 70% of the company’s future workforce growth in India. 
Tenthpin has also expanded its technology offerings in the advanced therapies segment. In July, the company announced that its Tenthpin Treatment Ordering Platform (T/TOP) for advanced therapies had become available through the SAP Store. The platform is aimed at supporting the ordering and coordination of personalised and advanced therapies. 
Earlier in the year, Tenthpin announced a collaboration with Amazon Web Services (AWS) to develop solutions for the Life Sciences industry. One of the initial outcomes of the partnership was Tenthpin Intelligent Certificate VerificAItion (T/ICV), an AI-powered solution designed to automate and strengthen certificate verification for pharmaceutical manufacturers and their supply partners. 
Tenthpin said the Bengaluru hub will form part of its global delivery network and contribute to the development of scalable digital solutions for Life Sciences companies worldwide. The company works with pharmaceutical, biotechnology, medtech, healthcare and animal health organisations and has positioned regulatory compliance as a key part of its technology implementations. It also said 16 of the world’s top 20 global pharmaceutical companies work with Tenthpin. 
Source PTI

Discussion

Have something to say? Post your comment